🐴 Weaver Brands acquires Shapley’s, adding premium equine grooming products and 1,200 global customers to its portfolio
💦 Corgi CEO reportedly threatened to shut NYC office over puppy pee pads and vet advice
🩺 Novel partners with Airvet to bring virtual vet care and next-day prescription delivery across Ontario
🚙 Subaru commits nearly $3.2m to shelters, helping thousands of pets find homes nationwide this October
🥩 Gran Canaria backs raw pet food startup Rawway with €100,000 to expand across the islands
🐱 New study finds heavy metals in nearly every cat food tested, but risk varies widely
🩸 Wagmo adds Wonderdog’s early disease detection tools to employee pet benefits ahead of open enrollment
💘 Brits say pets beat dating apps, with many calling their animals their true love instead
💉 Cats and dogs need different diabetes treatment strategies, with new drug options reshaping feline care
🇷🇺 Russia leads the world in cat ownership, yet 2.8 million strays remain across the country
💰 Would you spend $1000 a night for a premium luxury dog hotel?
Cats are living longer, but many age-related diseases still have limited treatment options. The Cat Health Company thinks that can change.
We spoke with Alexandru Bacita, co-founder and COO of The Cat Health Company, a clinical-stage biotech using machine learning to develop medicines for age-related diseases in cats. Bacita previously worked in human drug discovery before turning his attention to feline health.
In less than two years, the company says it has moved three drugs into clinical trials, built a pipeline of 11 more preclinical candidates, and out-licensed its first therapeutic. Its most advanced programs target age-related muscle loss and chronic kidney disease.
But the ambition goes beyond cats. Because cats naturally develop many of the same diseases of aging seen across mammals, the company believes what it learns could eventually help answer a much bigger question: how far can we extend healthy life?
Give us a short intro. What is The Cat Health Company, and what are you ultimately trying to accomplish?
We’re a clinical-stage biotech using machine learning to develop medicines for the diseases of old age in cats. In under two years, we’ve produced clinical-stage drugs, seen treatments make a real difference in very sick cats, and out-licensed our first therapeutic to pharma. Ultimately, we want to go beyond nine lives and then, beyond known limits for all species.
This one's for Pro members.
The Underbite Pro is how the pet industry's sharpest operators stay ahead.
Unlock This PostPro members get:
- Exclusive founder interviews and operator case studies
- Weekly deep-dive analysis on the trends moving the industry
- Data-driven insights reports you won't find anywhere else
- Masterclasses & live Q&As
- Full access to The Underbite's pro archive
